TrialBMC cancer2025

Impact of lenalidomide consolidation on health-related quality of life in chronic lymphocytic leukemia: ancillary study of the phase III CLL6-RESIDUUM trial.

Stephane Kroudia Wasse et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.